Top Stories
NHS hospitals in England could use the MRI-reading software for two years while gathering evidence on whether it improves cancer detection and reduces unnecessary biopsies.
The trio will work together to design adaptive clinical trials for Alzheimer's disease and other neurological conditions.
The partners plan to explore the virtual models across multiple disease areas, starting with lung health, in a bid to rethink drug trials.
Nearly 2000 AI agents analysed genetic experiments involving millions of mouse brain cells in about 30 minutes, identifying potential disease mechanisms for scientists to investigate.
An initial pilot will test the round-the-clock support tool in patients with desmoid tumours and NF1-related plexiform neurofibromas.
Conference News
• First human data presentation: Melina E. Marmarelis, MD, will present the ongoing Phase 1 program in a Rapid Oral session on October 25 in Madrid.• Mesothelioma focus: The investigational oral pan-...
Baseline plasma profiling identified three molecular states previously characterized in tissue: androgen receptor (AR)-high/metabolic, stem/epithelial–mesenchymal transition (EMT), and AR-low/prolifer...
Secures its 13th FDA 510(k) clearance, expanding its U.S. portfolio from lung nodule detection and coronary artery calcium (CAC) analysis to quantitative aortic assessmentEnables automated aortic segm...
Beta-CORRECT study shows a 10.6-fold higher risk of recurrence, reinforcing the prognostic value of molecular residual disease (MRD) testing1Building on its leadership in colorectal cancer screening w...
STAMPEDE study analysis providing new predictive evidence in clinically very high-risk, nonmetastatic disease to be presented at ESMOSOUTH SAN FRANCISCO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Vera...
